{"disease":{"id":"primary-open-angle-glaucoma","name":"primary open angle glaucoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03695224","title":"Matching Glaucoma With Impaired Cognition","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT04454190","title":"Development and Validation of a Model to Predict Fast Progression in Glaucoma","phase":"","overall_status":"TERMINATED","enrollment_count":1152,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT01881425","title":"InnFocus MicroShunt Versus Trabeculectomy Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":732,"lead_sponsor_name":"InnFocus Inc.","has_results":true},{"nct_id":"NCT03395535","title":"Laser-1st vs Drops-1st for Glaucoma and Ocular Hypertension","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":718,"lead_sponsor_name":"Moorfields Eye Hospital NHS Foundation Trust","has_results":false},{"nct_id":"NCT05022004","title":"A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":599,"lead_sponsor_name":"Sun Pharmaceutical Industries Limited","has_results":true},{"nct_id":"NCT04334564","title":"Effect of Ginkgo Biloba Capsule on Visual Function of Primary Open-angle Glaucoma With Blood Stasis Syndrome","phase":"NA","overall_status":"UNKNOWN","enrollment_count":512,"lead_sponsor_name":"Zhongshan Ophthalmic Center, Sun Yat-sen University","has_results":false},{"nct_id":"NCT01461278","title":"Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":505,"lead_sponsor_name":"Glaukos Corporation","has_results":false},{"nct_id":"NCT05181046","title":"Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":420,"lead_sponsor_name":"Nanodropper, Inc.","has_results":false},{"nct_id":"NCT03235232","title":"BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular Hypertension","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":406,"lead_sponsor_name":"EMS","has_results":false},{"nct_id":"NCT03762369","title":"A Clinical Study to Evaluate the Efficacy and Safety of CKD-351","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":384,"lead_sponsor_name":"Chong Kun Dang Pharmaceutical","has_results":false},{"nct_id":"NCT02617459","title":"Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":366,"lead_sponsor_name":"Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.","has_results":false},{"nct_id":"NCT05495061","title":"A Comparative Confirmatory Study of STN1012600 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":325,"lead_sponsor_name":"Santen Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT04742283","title":"Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":323,"lead_sponsor_name":"Santen Inc.","has_results":true},{"nct_id":"NCT00572455","title":"Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":318,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04736264","title":"Malay Glaucoma Eye Study II Navigation, Mobility and Reading Ability in Primary Glaucoma","phase":"NA","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Universiti Sains Malaysia","has_results":false},{"nct_id":"NCT02700984","title":"A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":282,"lead_sponsor_name":"Alcon Research","has_results":true},{"nct_id":"NCT04333433","title":"PRESERFLO® MicroShunt Extension Study","phase":"","overall_status":"COMPLETED","enrollment_count":279,"lead_sponsor_name":"InnFocus Inc.","has_results":true},{"nct_id":"NCT02623738","title":"A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study-","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":253,"lead_sponsor_name":"Santen Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT04620135","title":"Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular Hypertension","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":245,"lead_sponsor_name":"Aerie Pharmaceuticals","has_results":true},{"nct_id":"NCT02829996","title":"Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":201,"lead_sponsor_name":"Inotek Pharmaceuticals Corporation","has_results":true},{"nct_id":"NCT06692205","title":"Effects of Primary Open-angle Glaucoma on Visual-motor Coordination","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Zhongshan Ophthalmic Center, Sun Yat-sen University","has_results":false},{"nct_id":"NCT02006693","title":"Evaluation of the XEN Implant in Moderate Primary Open Angle Glaucoma (POAG) Participants","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":199,"lead_sponsor_name":"AqueSys, Inc.","has_results":true},{"nct_id":"NCT05439161","title":"XEN Glaucoma Gel Stent Versus Trabeculectomy","phase":"NA","overall_status":"RECRUITING","enrollment_count":196,"lead_sponsor_name":"Prof. Dr. Herbert Reitsamer","has_results":false},{"nct_id":"NCT04405245","title":"Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypertension or Open Angle Glaucoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":194,"lead_sponsor_name":"EyePoint Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT01915940","title":"Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":169,"lead_sponsor_name":"ForSight Vision5, Inc.","has_results":true},{"nct_id":"NCT02358369","title":"Dose-Ranging Study of the Bimatoprost Ocular Insert","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":156,"lead_sponsor_name":"ForSight Vision5, Inc.","has_results":true},{"nct_id":"NCT05279716","title":"Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag Isopropyl","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Santen Pharmaceutical Asia Pte. Ltd.","has_results":false},{"nct_id":"NCT03419975","title":"A Multi-center, Randomized, Blinded Evaluator, Active Control, Parallel, Phase III Study to Evaluate the Efficacy and Safety of TJO-002 in POAG or Ocular Hypertension Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":146,"lead_sponsor_name":"Taejoon Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT05940623","title":"Impact of Home Intraocular Pressure Telemonitoring on Intraocular Pressure Control and Glaucoma Progression","phase":"NA","overall_status":"UNKNOWN","enrollment_count":142,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT01442896","title":"STudy to Assess Rapid Disease Progression by Clinical and Genetic Factors In Glaucoma patientS That Are High Risk","phase":"","overall_status":"COMPLETED","enrollment_count":133,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT07418853","title":"Comparison of Goniotomy Device Outcomes in Combined Phacoemulsification-goniotomy Surgeries","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":132,"lead_sponsor_name":"Henry Ford Health System","has_results":false},{"nct_id":"NCT03931564","title":"SIGHT Study: Cost-effectiveness of InnFocus Microshunt Implantation vs. Trabeculectomy.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":124,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT05539508","title":"Role of Peripheral Vision in Scene Perception (PERISCE)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"University Hospital, Grenoble","has_results":false},{"nct_id":"NCT05973305","title":"Comparative Study of Dorzol Eye Drops, 20 mg/ml Versus Trusopt® Eye Drops, 20 mg/ml","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"Jadran Galenski laboratorij d.d.","has_results":false},{"nct_id":"NCT05973318","title":"Comparative Study of Dorzotimol Eye Drops, 20 mg/mL + 5 mg/mL Versus Cosopt® Eye Drops, 20 mg/mL + 5 mg/mL","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"Jadran Galenski laboratorij d.d.","has_results":false},{"nct_id":"NCT07322965","title":"Evaluation of BRUDYGLAUCO (DHA + Citicoline) in Patients With Glaucoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":108,"lead_sponsor_name":"Institut Catala de Retina","has_results":false},{"nct_id":"NCT02177123","title":"Post Market Study of the InnFocus MicroShunt","phase":"NA","overall_status":"COMPLETED","enrollment_count":107,"lead_sponsor_name":"InnFocus Inc.","has_results":true},{"nct_id":"NCT03697811","title":"DE-117 Spectrum 5 Study","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":107,"lead_sponsor_name":"Santen Inc.","has_results":true},{"nct_id":"NCT03331770","title":"Efficacy and Tolerability of an Innovative Formulation of BAK-free Latanoprost","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":103,"lead_sponsor_name":"Laboratorios Poen","has_results":false},{"nct_id":"NCT06903156","title":"Efficacy and Safety of Different Dosages of Mexidol® in Patients With Primary Open-angle Glaucoma (POAG)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Pharmasoft","has_results":false},{"nct_id":"NCT05351307","title":"Retinal Vascular Changes in Primary Open Angle Glaucoma Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT04448223","title":"A Clinical Study to Evaluate the Efficacy and Safety of CKD-351","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Chong Kun Dang Pharmaceutical","has_results":false},{"nct_id":"NCT05871034","title":"Electroretinogram and Retinal Vascular Changes After Cataract Surgery","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT04396002","title":"Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false},{"nct_id":"NCT06978101","title":"Visual Field Changes and OCT Angiographic Chorioretinal Changes in Patients With Primary Open Angle Glaucoma","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT04595227","title":"Glaucoma Screening Using Dynamic Analysis of Computerized Pupillary Light Reflex Assessment Device","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Peking University","has_results":false},{"nct_id":"NCT03858894","title":"Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Once Daily and Twice Daily in Subjects With Primary Open-Angle Glaucoma SPECTRUM 6","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":98,"lead_sponsor_name":"Santen Inc.","has_results":true},{"nct_id":"NCT02355990","title":"Minimally Invasive Micro Sclerostomy First in Man Safety and Preliminary Performance Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"Sanoculis Ltd","has_results":false},{"nct_id":"NCT02327312","title":"Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty","phase":"NA","overall_status":"TERMINATED","enrollment_count":91,"lead_sponsor_name":"Glaukos Corporation","has_results":false},{"nct_id":"NCT04284514","title":"Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AKB-9778 Ophthalmic Solution","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"Aerpio Therapeutics","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}